alexa Endovascular Procedures to treat HIV patients with associated Arterial Disease | OMICS International
ISSN: 2329-9495
Angiology: Open Access
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Endovascular Procedures to treat HIV patients with associated Arterial Disease

Paulo Eduardo Ocke Reis*

Department of Specialized and General Surgery, Fluminense Federal University, Rio de Janeiro, Brazil

*Corresponding Author:
Paulo Eduardo Ocke Reis
Department of Specialized and General Surgery
Fluminense Federal University, Rio de Janeiro, Brazil
Tel: +55 212629-5000
E-mail: [email protected]

Received date: 29 April, 2017; Accepted date: 02 May, 2017; Published date: 05 May, 2017

Citation: Reis PO (2017) Endovascular Procedures to treat HIV patients with associated Arterial Disease. Angiol 5:117. doi: 10.4172/2329-9495.1000e117

Copyright: © 2017 Reis PO. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Angiology: Open Access

Endovascular Procedures

Atherosclerotic and thrombotic disease associated with human immunodeficiency virus (HIV) infection has been studied, showing that HIV patients have 50% increased cardiovascular risk compared with the world population, contemporary, despite efforts, we cannot eradicate HIV and most patients will require lifelong treatment [1,2]. That modifies the arterial physiology inducing a variety of vasculopathies, as arterial aneurysms or occlusive disease [3-5]. Authors agree that endovascular therapy for the HIV-associated patients has good short-term results, [5-9] although guidelines for endovascular surgery in HIV-infected patients are currently nonexistent, open surgical management, is characterized by increased morbidity, mortality and poor limb salvage rates, however there is also no comparative study between surgical and endovascular options in the context of HIV [5,6]. In another hand results in endovascular first approach had good outcomes in HIV patients with artery aneurysms but were poor with occlusive disease [5]. We must keep in mind that thrombosis as a manifestation of HIV has already been reported characterizing a hypercoagulable state and that thromboembolic events may become more frequent in this group [2,9,10]. Thrombotic emergency has a raised risk of mortality and anticoagulation alone may not solve the problem, pharmacomechanical thrombolysis with recombinant tissue plasminogen activator and endovascular tools for rapid clot removal utilizing percutaneous mechanical device as Aspirex TM S-Straub Medical Aspirex® or Rotarex ® must be used for complete thrombus removal [10]. To treat vessels occlusion a successful percutaneous pharmacomechanical thrombectomy have been reported in patients infected with HIV [11].

Currently new endovascular devices, contribute to the technical development and improvement of our results in the general population but there are no structured guidelines advising on the respective roles of surgical and endovascular treatment for the management of vascular pathology in HIV patients [5,6,12]. Another important point of view is that endovascular technics have the advantage of reducing invasiveness, actually, the risk of HIV transmission should be considered and concerns regarding HIV transmission during any surgical procedures must be remembered [12].

For the future we already knows, in relation to the treatment of critical limb ischemia that it can interfere with both, the survival prognosis as in the rescue of members, patients with chronic HIV infection also. A member treated means reducing pain and improving quality of life fully, amputation may be an alternative to reduce pain, but decreases or prevents, in most cases, the opportunity for social rehabilitation and individual autonomy of patients [13].

In conclusion, besides the varied form of presentation and the small number of patients there are currently no long-term follow-up of those patients, but we can affirm that there is an extensive documentation of the association between vascular disease and HIV infection, however the applicability of these resources in this group of patients, which differs from classic atherosclerotic plaque, requires more time observation, although already supported by the literature we can consider the endovascular procedures an option for these patients.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • Annual Physicians Meeting 2018 May 11-12, 2018 Osaka, Japan
    May 11-12, 2018 Osaka, Japan
  • International Conference on Internal Medicine May 21-22, 2018 Osaka, Japan
    May 21-22, 2018 Osaka, Japan
  • 7th International Conference on Clinical and Medical Case Reports June 01-02, 2018 Osaka, Japan
    June 01-02, 2018 Osaka, Japan
  • ICACCM 2018 : 20th International Conference on Anesthesiology and Critical Care MedicineToronto, Canada June 21 - 22, 2018
    June 21-22, 2018 Dublin, Ireland
  • 7th International Conference and Exhibition on Surgery June 21-23, 2018 Dublin, Ireland
    June 21-23, 2018 Dublin, Ireland Dublin, Ireland

Article Usage

  • Total views: 401
  • [From(publication date):
    June-2017 - Jan 24, 2018]
  • Breakdown by view type
  • HTML page views : 355
  • PDF downloads : 46
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version